Now, fibromyalgia is making a potential appearance on this management list, according to a Medscape article Reporting on a large-scale health records analysis, the article states The use of GLP-1 receptor agonists was linked to lower pain and fatigue in patients with fibromyalgia The way that I use it in my practice these days is that if I have a patient with chronic pain or with fibromyalgia who has comorbidities that already have an FDA approval for GLP-1 use, such as obesity, diabetes, or obstructive sleep apnea, I would encourage them to go to their primary care physician and maybe consider getting started on a GLP-1, said presenter Nouran Eshak, MB ChB, of the Mayo Clinic in Scottsdale, Arizona. However, the article also lists several limitations to the study including Researchers were unable to account for confounders such as duration of illness, symptom severity, GLP-1 dosage, or access to healthcare. Disclaimer: This post is not a recommendation, rather just a report

Most protocol failures happen in the first 72 hours after mixing, when researchers unknowingly expose reconstituted peptides to temperature fluctuations that irreversibly denature the protein structure
All doses of Zepbound have the same 5-day half-life, Dr
Tirzepatide, on the other hand, is unique because it acts on two hormones GLP-1 (like Semaglutide) and GIP (glucose-dependent insulinotropic polypeptide)
So, can you stack Tesamorelin and Sermorelin